J Korean Ophthalmol Soc.  2021 Jan;62(1):120-126. 10.3341/jkos.2021.62.1.120.

Autosomal Dominant Drusen Confirmed by Molecular Genetics

• Song JS
• Oh BL
• Park UC
• Yu HG
• Lee EK

• KMID: 2511534
• DOI: http://doi.org/10.3341/jkos.2021.62.1.120

Abstract

Purpose
To report a case of autosomal dominant drusen confirmed by molecular genetic testing and the clinical features and findings of a multimodal diagnostic imaging study.
Case summary
A 32-year-old male presented with decreased visual acuity in his right eye from 1 year prior to his first visit. On the first visit, his visual acuities were 0.3 in the right eye and 1.2 in the left eye. A fundus examination showed numerous drusen of various sizes widely distributed on the posterior pole of both eyes, as well as subretinal fibrotic change with pigmentation in the right eye. Optical coherence tomography showed extensive hyperreflective deposits beneath the retinal pigment epithelium in both eyes and small amounts of cystic intraretinal fluid in the right eye. Fluorescein angiography and fundus autofluorescence showed the drusen as multiple hyperfluorescent spots, while indocyanine green angiography indicated hypofluorescence corresponding to the drusen. Genetic sequence analysis revealed a pathogenic variant of the EFEMP1 gene, heterozygous c.1033C>T (p.Arg345Trp), which accords with the diagnosis of autosomal dominant drusen. Intravitreal bevacizumab injection was given in the right eye; however, there was no improvement in the amount of intraretinal fluid nor visual acuity.
Conclusions
Autosomal dominant drusen is a very rare disease. It is necessary to distinguish it from age-related macular degeneration, as the affected age and clinical features of drusen are different, including the response to anti-vascular endothelial growth factor treatment.

Keyword

Autosomal dominant drusen, Doyne honeycomb retinal dystrophy, EFEMP1 gene, Malattia leventinese, Multimodal imaging